National HealthCare Co. (NYSE:NHC) Shares Sold by Summit Global Investments

Summit Global Investments lessened its stake in shares of National HealthCare Co. (NYSE:NHC - Free Report) by 40.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,423 shares of the company's stock after selling 4,328 shares during the quarter. Summit Global Investments' holdings in National HealthCare were worth $808,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Robeco Institutional Asset Management B.V. raised its holdings in shares of National HealthCare by 223.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 20,899 shares of the company's stock worth $2,628,000 after purchasing an additional 14,445 shares during the period. Nisa Investment Advisors LLC increased its holdings in shares of National HealthCare by 5.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 4,091 shares of the company's stock worth $517,000 after buying an additional 206 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its stake in National HealthCare by 1,277.1% during the third quarter. DekaBank Deutsche Girozentrale now owns 10,411 shares of the company's stock worth $1,255,000 after purchasing an additional 9,655 shares during the last quarter. Ballentine Partners LLC bought a new stake in National HealthCare in the 3rd quarter worth approximately $223,000. Finally, Copeland Capital Management LLC bought a new position in shares of National HealthCare during the 3rd quarter valued at $62,000. Institutional investors and hedge funds own 56.44% of the company's stock.

National HealthCare Stock Up 3.5 %

NYSE:NHC traded up $4.51 on Friday, reaching $134.43. 53,958 shares of the stock traded hands, compared to its average volume of 43,327. The firm has a market capitalization of $2.07 billion, a P/E ratio of 22.67 and a beta of 0.41. National HealthCare Co. has a 12 month low of $70.03 and a 12 month high of $138.49. The stock's fifty day moving average is $123.72.

National HealthCare (NYSE:NHC - Get Free Report) last issued its quarterly earnings data on Friday, August 9th. The company reported $1.00 earnings per share (EPS) for the quarter. National HealthCare had a net margin of 7.74% and a return on equity of 6.39%. The firm had revenue of $300.66 million during the quarter.

Analyst Ratings Changes

Separately, StockNews.com downgraded National HealthCare from a "strong-buy" rating to a "buy" rating in a report on Friday.

Insider Buying and Selling

In related news, SVP Brian F. Kidd sold 2,000 shares of the firm's stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.01, for a total value of $260,020.00. Following the completion of the transaction, the senior vice president now directly owns 21,747 shares of the company's stock, valued at approximately $2,827,327.47. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 13.75% of the stock is owned by insiders.

National HealthCare Profile

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.